It would have been a very tough case to make you would have had to show him that there was a material adverse effect and they tried everything they could define one with the whistleblower and the other stuff. It's very difficult to prove that in these cases we've only had one real MAE case down here in Delaware in the 50 years that this has been going on so they just probably came to the conclusion that couldn't get up get up the mountain on it. But I do believe Elon Musk who kind of charts his own course no doubt about it Jeff.
Bloomberg News Legal Reporter Jef Feeley explains why Elon Musk is reviving his original deal to buy Twitter at the price of $54.20 a share. Bloomberg Balance of Power Anchor David Westin discusses Micron's plan for a $100 billion for semiconductor factory in New York. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Riley Griffin provide the details of Riley's Businessweek Magazine story Pfizer Needs to Prove That It’s Ready to Move On From Covid-19. Stewart Glickman, Head of Energy Research at CFRA, talks about investing in energy firms in this inflationary environment. And we Drive to the Close with Sylvia Jablonski, CEO at Defiance ETFs.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.